Full Press Release Details
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares.
IMTX
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
Key Takeaway: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
Price reaction · baseline $10.09 (2022-10-07 close) · clean, no other IMTX news in the window
day 0 close
+11.6%
day 1
+9.9%
day 3
+11.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+20%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Lead asset
IMA401
Phase 1 · Refractory Cancer